New registry study aims to improve sepsis treatment with ARTICE® therapy
NCT ID NCT07388628
First seen Feb 05, 2026 · Last updated May 16, 2026 · Updated 9 times
Summary
This study is collecting real-world data from 200 adults with sepsis or septic shock who receive ARTICE® therapy in the ICU. Researchers will track organ function, lab markers, survival, and complications to better understand how well the treatment works and who benefits most. The goal is to improve care for critically ill patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Klinikum Magdeburg, Klinik für Intensiv- und Rettungsmedizin
RECRUITINGMagdeburg, 39130, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.